https://orcid.org/0000-0003-2747-935X
References
- Trescot AM, Helm S, Hansen H, et al. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians’ (ASIPP) guidelines. Pain Physician. 2008;11(2 Suppl):S5–S62.
- Stanos S. Evolution of opioid risk management and review of the classwide REMS for extended-release/long-acting opioids. Phys Sportsmed. 2012;40(4):12–20. doi:10.3810/psm.2012.11.1975
- U.S. Food and Drug Administration. Risk Evaluation and Mitigation Strategy (REMS) for Extended-Release and Long-Acting Opioids, 2013. Available from: https://www.fda.gov/downloads/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/UCM311290.pdf. Accessed February 17, 2021.
- Rudd RA, Aleshire N, Zibbell JE, Gladden RM. Increases in drug and opioid overdose deaths–United States, 2000–2014. MMWR Morb Mortal Wkly Rep. 2016;64(50–51):1378–1382. doi:10.15585/mmwr.mm6450a3
- Hasegawa K, Espinola JA, Brown DF, Camargo CA Jr. Trends in U.S. emergency department visits for opioid overdose, 1993–2010. Pain Med. 2014;15(10):1765–1770. doi:10.1111/pme.12461
- Dart RC, Surratt HL, Cicero TJ, et al. Trends in opioid analgesic abuse and mortality in the United States. N Engl J Med. 2015;372(3):241–248. doi:10.1056/NEJMsa1406143
- Divino V, Cepeda MS, Coplan P, Maziere JY, Yuan Y, Wade RL. Assessing the impact of the extended-release/long-acting opioid an-algesics risk evaluation and mitigation strategies on opioid prescription volume. J Opioid Manag. 2017;13(3):157–168. doi:10.5055/jom.2017.0383
- Hays RD, Liu H, Kapteyn A. Use of internet panels to conduct surveys. Behav Res Methods. 2015;47(3):685–690. doi:10.3758/s13428-015-0617-9
- Knox C, Hampp C, Willy M, Winterstein AG, Pan GD. Patient understanding of drug risks: an evaluation of medication guide assessments. Pharmacoepidemiol Drug Saf. 2015;24(5):518–525. doi:10.1002/pds.3762